We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Improved Medical Implants Could Influence Immune System to Help Instead of Harming the Body

By HospiMedica International staff writers
Posted on 25 Oct 2023
Print article
Image: New insight into immune response forges a path toward improved medical implants (Photo courtesy of NIH Medical Arts)
Image: New insight into immune response forges a path toward improved medical implants (Photo courtesy of NIH Medical Arts)

Medical implants like pacemakers, breast implants, or knee replacements can sometimes create unfavorable immune reactions that harm both the implant and the nearby tissue. The standard clinical approach to handle this has been to use immunosuppressive drugs, which don't always work effectively and carry significant risks. When these immune-related complications arise, patients often require additional surgeries to replace or remove the compromised implants. Though scientists don't yet fully understand why these immune responses occur, new research is shedding light on some crucial factors.

Natural implants, such as tissue grafts, have been found to guide the immune system in a more positive direction by encouraging healing processes. While natural materials can't be used for all medical applications, the lessons they provide can be valuable for other types of implants. Researchers at the National Institute of Biomedical Imaging and Bioengineering (NIBIB, Bethesda, MD, USA) studied how the immune system reacts differently to two materials implanted in mice. Their findings help lay the groundwork for designing medical devices that could work in harmony with the immune system, rather than against it.

To explore the differences in immune responses to various materials, scientists removed muscle from the legs of mice and filled the gaps with two different materials. One was decellularized small intestinal submucosa, which is pig tissue stripped of its cells, leaving mostly collagen. This material has been shown to encourage healing processes. The other was polyethylene, a plastic often used in orthopedic implants, known to cause long-term inflammation and scarring. A third group of mice with muscle removed was left untreated as a control group.

By employing flow cytometry, the researchers identified and counted various cell types in the tissue taken from the mice. As anticipated, samples with the submucosa showed a greater tendency towards anti-inflammatory reactions and healing compared to the polyethylene samples. Notably, one specific cell type, called cDC1s and belonging to the dendritic cell class, was much more prevalent in the submucosa samples. Dendritic cells help the immune system distinguish between harmful and harmless entities. When these dendritic cells were genetically blocked in mice, both inflammation and scarring increased, irrespective of the implanted material.

Additional experiments revealed that a type of immune cell called natural killer cells were signaling for the recruitment of this specific dendritic cell subtype, a process commonly seen in tumor-related immune responses. The researchers believe that molecular signals likely present in pig submucosa but not in polyethylene could be the reason for the different immune reactions observed. Moving forward, the research team aims to pinpoint the specific proteins and molecules that trigger these healing responses. Their goal is to incorporate these molecules into existing or new medical devices to make them more compatible with the body's immune system, thus increasing their safety and longevity.

“Implants frequently cause pain and, in many cases, need to be removed within a few years. We’re looking to eventually eliminate that grief by extending the lifespan of implanted medical devices to the lifespan of patients,” said Kaitlyn Sadtler, Ph.D., Earl Stadtman Tenure-Track Investigator and chief of the Section on Immunoengineering at NIBIB. “If we could tease out what aspect of these different materials causes certain immune responses, we would have more control in designing materials and devices that encourage the responses we want.”

Related Links:
NIBIB 

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Patient Monitor
UM2012

Print article

Channels

Critical Care

view channel
Image: Peerbridge Cor is a 3-lead, 2-channel wireless AECG that simplifies the testing and diagnostic process (Photo courtesy of Peerbridge Health)

First-of-its-Kind Trial to Measure Ejection Fraction Severity Directly from AI-Enabled Remote ECG Wearable

Echocardiograms are a standard diagnostic tool to measure ejection fraction but require a clinical setting for administration. This can pose challenges such as scheduling delays, staffing shortages, accessibility... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.